ctrl K

eFFECTOR Therapeutics Inc... (EFTR)

OTC: EFTR · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Mar 06, 2025, 9:31 AM

eFFECTOR Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	3.55M	1.43M	42M	n/a
Cost of Revenue	111K	53K	24K	21.83M	307K
Gross Profit	-22.92M	3.5M	1.41M	20.17M	-307K
Operating Income	-33.84M	-32.4M	-31.9M	15.82M	-28.61M
Interest Income	1.95M	439K	6K	67K	239K
Pretax Income	-35.81M	-22.66M	15.8M	14.56M	-29.74M
Net Income	-35.81M	-12.93M	15.8M	14.21M	-29.74M
Selling & General & Admin	10.93M	12.64M	13.37M	4.35M	4.71M
Research & Development	22.92M	23.31M	19.96M	21.83M	23.58M
Other Expenses	n/a	-3.55M	-1.43M	9K	n/a
Operating Expenses	33.84M	32.4M	31.9M	26.18M	28.3M
Interest Expense	n/a	2.25M	1.76M	1.33M	1.38M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	33.84M	32.4M	31.9M	26.18M	28.61M
Income Tax Expense	n/a	-9.74M	-24K	351K	135.14K
Shares Outstanding (Basic)	2.19M	1.65M	1.62M	598.56K	552.43K
Shares Outstanding (Diluted)	2.19M	1.65M	1.62M	598.56K	552.43K
EPS (Basic)	-16.37	-7.85	9.78	23.74	-53.83
EPS (Diluted)	-16.37	-7.85	9.78	23.74	-53.83
EBITDA	-33.73M	-32.4M	-31.9M	16.05M	-28.3M
EBIT	-38.73M	-20.41M	17.56M	15.89M	-28.36M
Depreciation & Amortization	111K	53K	24K	160K	307K